michigan semaglutide stomach paralysis class action Ozempic, Mounjaro manufacturers sued over risk of How Semaglutide Causes Stomach Paralysis
Description
Patients treated with GLP-1RA will need to self-inject agents or have them administered subcutaneously anywhere from twice daily to once weekly depending on formulation

After 4 weeks at 2.5 mg, increase to 5 mg if tolerated

Remedy Meds: Medication-Centered Telehealth Model Remedy Meds positions itself as a direct-to-consumer telehealth service focused on GLP-1 receptor agonist prescriptions, primarily semaglutide and tirzepatide formulations

[DOI] [PubMed] [Google Scholar] 85.St Andre J, Albanos K, Reilly S

Additionally, further research is needed to elucidate whether GLP-1/GIP agonists confer benefits in OSA that extend beyond their effects on weight loss
